Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

IDEAYA Biosciences (IDYA) Income from Continuing Operations: 2019-2024

Historic Income from Continuing Operations for IDEAYA Biosciences (IDYA) over the last 6 years, with Dec 2024 value amounting to -$327.0 million.

  • IDEAYA Biosciences' Income from Continuing Operations rose 262.13% to $108.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$167.5 million, marking a year-over-year increase of 25.47%. This contributed to the annual value of -$327.0 million for FY2024, which is 143.23% down from last year.
  • IDEAYA Biosciences' Income from Continuing Operations amounted to -$327.0 million in FY2024, which was down 143.23% from -$134.4 million recorded in FY2023.
  • In the past 5 years, IDEAYA Biosciences' Income from Continuing Operations registered a high of -$35.3 million during FY2020, and its lowest value of -$327.0 million during FY2024.
  • Over the past 3 years, IDEAYA Biosciences' median Income from Continuing Operations value was -$134.4 million (recorded in 2023), while the average stood at -$174.6 million.
  • Per our database at Business Quant, IDEAYA Biosciences' Income from Continuing Operations increased by 20.16% in 2020 and then crashed by 143.23% in 2024.
  • Yearly analysis of 5 years shows IDEAYA Biosciences' Income from Continuing Operations stood at -$35.3 million in 2020, then slumped by 42.22% to -$50.3 million in 2021, then dropped by 24.34% to -$62.5 million in 2022, then tumbled by 115.08% to -$134.4 million in 2023, then crashed by 143.23% to -$327.0 million in 2024.